RPL6 (Gene)

Synonyms:ENTREZ:6128, HGNC:10362, L6, MIM:603703, NM_000970, NM_001024662, NM_001320137, NM_001320138, NM_001320139, NM_001320140, NM_001320141, NM_001320142, NP_000961, NP_001019833, NP_001307066, NP_001307067, NP_001307068, NP_001307069, NP_001307070, NP_001307071, RPL6, SHUJUN-2, TAXREB107, TXREB1, XM_017019781, XM_017019782, XP_016875270, XP_016875271, ribosomal protein L6
Omim:OMIM:603703
Id:ENSG00000089009
Hgnc:HGNC:10362
Entrez:6128
Description:ribosomal protein L6
This gene encodes a protein component of the 60S ribosomal subunit. This protein can bind specifically to domain C of the tax-responsive enhancer element of human T-cell leukemia virus type 1, and may participate in tax-mediated transactivation of transcription. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed throughout the genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View RPL6's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with RPL6.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using RPL6.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for RPL6.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with RPL6.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.